Aidoc, a Tel Aviv, Israel-based provider of healthcare AI solutions, raised $110m in Series D funding.
The round, which brought total funding to $250m, was co-led by global growth investors TCV and Alpha Intelligence Capital (AIC), with participation from AIC’s co-investor CDIB Capital.
The company intends to use the funds for the continued expansion of the Aidoc AI Care Platform.
Led by Elad Walach, CEO, Aidoc provides artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance operational capabilities. Its AI Care Platform offers health systems a singular platform solution that works with physicians to manage the entire patient lifecycle—from diagnostic aid, to consultation to suggested treatment paths to patient follow-up tools. In clinical studies, the Aidoc AI has proven to reduce turnaround time, shorten patient length of stay and improve patient outcomes.